This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Allergy to Mites
and you are
between 18 and 50
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The objective of this study is to determine the biologic activity of a Blomia tropicalis allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

Provided treatments

  • Biological: Four different concentrations of Blomia tropicalis allergen extract, positive control and negative control
Tris trial is registered with FDA with number: NCT01597752. The sponsor of the trial is Laboratorios Leti, S.L. and it is looking for 20 volunteers for the current phase.
Official trial title:
Biological Standardization of Blomia Tropicalis Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units